Trials / Unknown
UnknownNCT04724876
Meningitis Encephalitis: a Metagenomics-Based Etiology & Epidemiology Research
Meningitis Encephalitis: a Metagenomics-Based Etiology & Epidemiology Research (MEMBER Research)
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (estimated)
- Sponsor
- Beijing Tongren Hospital · Academic / Other
- Sex
- All
- Age
- 14 Years
- Healthy volunteers
- Not accepted
Summary
Autoimmune encephalitis (AE) is caused by abnormal immune response mediated by autoimmune antibodies of patients, which can be detected by a serial of autoimmune antibodies\[4,5,6,7\]. At present, the traditional infection diagnosis mainly relies on microbial culture method, which has the characteristics of long cycle, high cost, low detection rate and complex detection process. About 30-60% of encephalitis have unknown etiology\[2,3\]. On the other hand, the diagnosis and classification of noninfectious encephalitis mainly depend on the detection of autoimmune antibodies, the scope of diagnosis and differential diagnosis is limited, and the relationship between autoimmune encephalitis and infection factors is still unclear. Metagenomics sequencing (mNGS) is a new method that does not rely on microbial culture and can directly detect pathogenic nucleic acids. It has the characteristics of fast, accurate, high throughput, no preference for different pathogen detection, and can detect known and unknown pathogens at the same time. Nowadays, mNGS is widely used in the field of pathogen detection.
Conditions
Timeline
- Start date
- 2020-12-31
- Primary completion
- 2023-06-01
- Completion
- 2023-06-01
- First posted
- 2021-01-26
- Last updated
- 2021-01-26
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04724876. Inclusion in this directory is not an endorsement.